A Hydrochloride, Glycine CEP of the European Pharmacopoeia monograph is often referred to as a Hydrochloride, Glycine Certificate of Suitability (COS). The purpose of a Hydrochloride, Glycine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydrochloride, Glycine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydrochloride, Glycine to their clients by showing that a Hydrochloride, Glycine CEP has been issued for it. The manufacturer submits a Hydrochloride, Glycine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydrochloride, Glycine CEP holder for the record. Additionally, the data presented in the Hydrochloride, Glycine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydrochloride, Glycine DMF.
A Hydrochloride, Glycine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydrochloride, Glycine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydrochloride, Glycine suppliers with CEP (COS) on PharmaCompass.